Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1996 | 09-1996 | 06-1996 | 03-1996 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 5,484 | 13,609 | 4,453 | N/A |
| Marketable Securities | 25,503 | 11,072 | 10,696 | N/A |
| Other current assets | 256 | 37 | 54 | 0 |
| TOTAL | $31,243 | $24,718 | $15,203 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 11,380 | 11,041 | 10,954 | N/A |
| Other Non-Current Assets | 640 | 0 | 0 | 0 |
| TOTAL | $12,020 | $11,041 | $10,954 | $N/A |
| Total Assets | $37,001 | $30,655 | $21,437 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 1,227 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 651 | 0 | 0 | 0 |
| Accrued Expenses | 3,065 | N/A | N/A | N/A |
| TOTAL | $4,943 | $3,977 | $4,315 | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 2,004 | 2,293 | 2,598 | N/A |
| TOTAL | $2,004 | $2,293 | $2,598 | $N/A |
| Total Liabilities | $6,947 | $6,270 | $6,913 | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 51,810 | 51,809 | 51,809 | N/A |
| Retained earnings | -74,082 | N/A | N/A | N/A |
| Other shareholders' equity | 52,326 | -27,424 | -37,285 | 0 |
| TOTAL | $30,054 | $24,385 | $14,524 | $N/A |
| Total Liabilities And Equity | $37,001 | $30,655 | $21,437 | $0 |